J. Christopher Naftzger is General Counsel and CCO of Arbutus Biopharma Corp. Currently has a direct ownership of 95,100 shares of ABUS, which is worth approximately $346,164. The most recent transaction as insider was on Feb 01, 2024, when has been sold 95,100 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.1K
0% 3M change
n/a 12M change
Total Value Held $346,164

J. Christopher Naftzger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
BUY
Grant, award, or other acquisition
-
95,100 Added 50.0%
95,100 Common Shares

Also insider at

NBRV
Nabriva Therapeutics plc Healthcare
JCN

J. Christopher Naftzger

General Counsel and CCO
Fort Washington, PA

Track Institutional and Insider Activities on ABUS

Follow Arbutus Biopharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

News

Receive news related to Arbutus Biopharma Corp

Track Activities on ABUS